Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Shenzhen Kangtai Biological Products

1988 FOUNDED
PUBLIC STATUS
1K-5K EMPLOYEES
300601 STOCK SYMBOL
$10.03 SHARE PRICE (As of Monday Closing)
Description

Shenzhen Kangtai Biological Products Co Ltd is a human vaccine research and development company. The company is engaged in the research and development, production and sales of recombinant hepatitis B vaccine, b -type influenza Haemophilus conjugate vaccine, measles-rubella combined live attenuated vaccine, cell-free baibai broke b Haemophilus influenzae vaccine and other products.

Ownership Status
Publicly Held
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Stock Exchange
SHE
Primary Office
  • Kefa Road 6, Science & Industry Park
  • Nanshan
  • Shenzhen
  • China

+86 0755 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Shenzhen Kangtai Biological Products’s full profile, request a free trial.

Shenzhen Kangtai Biological Products Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$4.11 - $10.91 $6.47B $10.05 4.29M 645M

Shenzhen Kangtai Biological Products Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 4,926,065 3,340,773 3,078,175
Revenue 258,078 304,885 171,824 82,864
EBITDA 68,538 85,308 44,079 22,004
Net Income 59,724 65,860 31,771 12,943
Total Assets 513,375 485,019 338,615 230,551
Total Debt 45,615 68,104 45,993 52,198
Public Fundamental Data provided by Morningstar, Inc. disclaimer